Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Provention Bio Inc (PRVB)

Provention Bio Inc (PRVB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wall Street Analysts Predict a 167% Upside in Provention Bio, Inc. (PRVB): Here's What You Should Know

The consensus price target hints at a 167.3% upside potential for Provention Bio, Inc. (PRVB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

PRVB : 6.95 (+0.72%)
Provention Bio, Inc. (PRVB) Upgraded to Buy: What Does It Mean for the Stock?

Provention Bio, Inc. (PRVB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PRVB : 6.95 (+0.72%)
How Much Upside is Left in Provention Bio, Inc. (PRVB)? Wall Street Analysts Think 187%

The average of price targets set by Wall Street analysts indicates a potential upside of 187.1% in Provention Bio, Inc. (PRVB). While the effectiveness of this highly sought-after metric is questionable,...

PRVB : 6.95 (+0.72%)
Provention Bio, Inc. (PRVB) Reports Q3 Loss, Misses Revenue Estimates

Provention Bio, Inc. (PRVB) delivered earnings and revenue surprises of 8.51% and -81.92%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?...

PRVB : 6.95 (+0.72%)
Provention Bio to Report Third Quarter 2021 Financial Results on November 4, 2021

/PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today...

PRVB : 6.95 (+0.72%)
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Provention Bio and Ontrak on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Provention Bio, Inc. (NASDAQ:...

PRVB : 6.95 (+0.72%)
OTRK : 5.85 (-3.62%)
Lifshitz Law Firm, P.C. Announces Investigations of ContextLogic, Inc. (NasdaqGS: WISH), Provention Bio, Inc. (NasdaqGS: PRVB), Ubiquiti Inc. (NYSE: UI), and Virgin Galactic holdings, Inc. (NYSE: SPCE)

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- ContextLogic, Inc. (NasdaqGS: WISH)

WISH : 3.35 (-10.19%)
PRVB : 6.95 (+0.72%)
UI : 296.67 (-0.88%)
SPCE : 14.86 (-7.13%)
Last Few Hours to Actively Participate in Provention Bio, Inc. (PRVB) Class Action - Bronstein, Gewirtz & Grossman, LLC

NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Provention Bio, Inc. ("Provention"...

PRVB : 6.95 (+0.72%)
DEADLINE ALERT for UI, PRVB, and WPG: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 19, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...

UI : 296.67 (-0.88%)
PRVB : 6.95 (+0.72%)
WPG : 0.8323 (-1.00%)
PRVB Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Provention Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 20, 2021

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB) and certain...

PRVB : 6.95 (+0.72%)

Barchart Exclusives

3 Iron Condor Trade Ideas For December 2nd
An iron condor aims to profit from a drop in implied volatility, with the stock staying within an expected range. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar